ZFA-Logo

Origin of a „Drug List from the Family Doctor’s Practice“

DOI: 10.3238/zfa.2015.0452-0455

Erfahrungen und Ergebnisse des 7. Professionalisierungskurses der Deutschen Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)

german translation / full article

Christoph Bideau, Anton J. Beck

Keywords: Drug list Faculty Development Family Practice Group Building Group Discussion

Experiences and results of the 7th Faculty Development Fellowship Programm of the German College of General Practitioners and Family Physicians (DEGAM)

Background: During the 7. Faculty Development Fellowship Program 13 experienced family practitioners, doctors in advanced vocational training and colleagues working at academic institutions compiled a list of 100 drugs, alphabetically arranged according to indication, pharmaceutical form, dosage, effects and adverse drug reactions relevant to everyday practice. This article illustrates how we created the list, our approach and our methods.

Methods: During a total of seven meetings throughout Germany 13 of the original 18 participants compiled a “Drug List from Family Practice”. This list aims to inform trainees, students, medical assistants and family practitioners about 100 important drugs commonly used in daily practice.Various methods of moderated group discussions were used, with the potential benefits derived from social interaction during each meeting. We also developed a specific approach to selecting drugs; this resulted in the creation of a “Drug List from Family Practice”.

Results: Recognizing and analyzing issues associated with group dynamics, moderated group discussions and installing a leadership group together with the use of networking and support of social interaction enabled the participants to design the list. Format and layout of the list could easily be integrated in everyday practice and supported its use by the target audience. Where applicable, all active substances were compared with family medicine guidelines or national health care guidelines, and – if possible – with studies that had been published independent of the pharmaceutical industry.

Conclusions: Concerning their scientific and practical experience and their personal preferences the group participants were heterogenous. This factors led to lively discussions when selecting the drugs, but enhanced the selection process and made a balanced selection of pharmaceutical substances possible. Building a leadership group and moderated group discussions enabled discipline at work and avoided excessive demands on individual participants. Also, the framing programme was instrumental to achieve a positive work atmosphere.


(State: 18.11.2015)

Latest Issue 9/2020

In Focus

  • Clinical Characteristics of SARS-CoV-2 Tested Patients
  • Urinary Incontinence in Family Practice
  • Challenges in Southern Bavarian Primary Care Practices During the COVID-19 Pandemic